Demerol (Meperidine) Market Report

Japan Demerol (Meperidine) Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major Region

  • POSTDATE：May 29, 2020
  • PAGES：157
  • REPORT CODE：GMM533494
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report offers an overview of the market trends, drivers, and barriers with respect to the Japan Demerol (Meperidine) market. It also provides a detailed overview of the market of different regions across Hokkaido, Tohoku, Kanto, Chubu, Kinki, Chugoku, Shikoku, Kyushu. The report deep analyzes type and application in Japan Demerol (Meperidine) market. Detailed analysis of key players, along with key growth strategies adopted by Demerol (Meperidine) industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Endo Pharmaceuticals

    • Boehringer Ingelheim

    • Sun Pharmaceuticals

    • Purdue Pharma

    • Actavis

    • Egalet

    • Mallinckrodt Pharmaceuticals

    • Janssen

    • Pfizer

    • Sanofi

    By Type:

    • Powder

    • Liquid

    By End-User:

    • Anesthesia

    • Cough Treatment

    • Diarrhea Treatment

    By Region:

    • Hokkaido

    • Tohoku

    • Kanto

    • Chubu

    • Kinki

    • Chugoku

    • Shikoku

    • Kyushu

  • 1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Demerol (Meperidine) Market

    • 1.3 Market Segment by Type

      • 1.3.1 Japan Demerol (Meperidine) Market Size and Growth Rate of Powder from 2014 to 2026

      • 1.3.2 Japan Demerol (Meperidine) Market Size and Growth Rate of Liquid from 2014 to 2026

    • 1.4 Market Segment by Application

      • 1.4.1 Market Size and Growth Rate of Anesthesia

      • 1.4.2 Market Size and Growth Rate of Cough Treatment

      • 1.4.3 Market Size and Growth Rate of Diarrhea Treatment

    • 1.5 Market Segment by Regions

      • 1.5.1 Hokkaido Demerol (Meperidine) Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Tohoku Demerol (Meperidine) Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Kanto Demerol (Meperidine) Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Chubu Demerol (Meperidine) Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Kinki Demerol (Meperidine) Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Chugoku Demerol (Meperidine) Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Shikoku Demerol (Meperidine) Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Kyushu Demerol (Meperidine) Consumption Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Demerol (Meperidine) Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Demerol (Meperidine) by Major Types

      • 3.4.1 Japan Demerol (Meperidine) Market Size and Growth Rate of Powder from 2014 to 2026

      • 3.4.2 Japan Demerol (Meperidine) Market Size and Growth Rate of Liquid from 2014 to 2026

    4 Segmentation of Demerol (Meperidine) Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Demerol (Meperidine) by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Demerol (Meperidine) in Anesthesia

      • 4.4.2 Market Size and Growth Rate of Demerol (Meperidine) in Cough Treatment

      • 4.4.3 Market Size and Growth Rate of Demerol (Meperidine) in Diarrhea Treatment

    5 Market Analysis by Regions

    • 5.1 Japan Demerol (Meperidine) Production Analysis by Regions

    • 5.2 Japan Demerol (Meperidine) Consumption Analysis by Regions

    6 Hokkaido Demerol (Meperidine) Landscape Analysis

    • 6.1 Hokkaido Demerol (Meperidine) Landscape Analysis by Major Types

    • 6.2 Hokkaido Demerol (Meperidine) Landscape Analysis by Major End-Users

    7 Tohoku Demerol (Meperidine) Landscape Analysis

    • 7.1 Tohoku Demerol (Meperidine) Landscape Analysis by Major Types

    • 7.2 Tohoku Demerol (Meperidine) Landscape Analysis by Major End-Users

    8 Kanto Demerol (Meperidine) Landscape Analysis

    • 8.1 Kanto Demerol (Meperidine) Landscape Analysis by Major Types

    • 8.2 Kanto Demerol (Meperidine) Landscape Analysis by Major End-Users

    9 Chubu Demerol (Meperidine) Landscape Analysis

    • 9.1 Chubu Demerol (Meperidine) Landscape Analysis by Major Types

    • 9.2 Chubu Demerol (Meperidine) Landscape Analysis by Major End-Users

    10 Kinki Demerol (Meperidine) Landscape Analysis

    • 10.1 Kinki Demerol (Meperidine) Landscape Analysis by Major Types

    • 10.2 Kinki Demerol (Meperidine) Landscape Analysis by Major End-Users

    11 Chugoku Demerol (Meperidine) Landscape Analysis

    • 11.1 Chugoku Demerol (Meperidine) Landscape Analysis by Major Types

    • 11.2 Chugoku Demerol (Meperidine) Landscape Analysis by Major End-Users

    12 Shikoku Demerol (Meperidine) Landscape Analysis

    • 12.1 Shikoku Demerol (Meperidine) Landscape Analysis by Major Types

    • 12.2 Shikoku Demerol (Meperidine) Landscape Analysis by Major End-Users

    13 Kyushu Demerol (Meperidine) Landscape Analysis

    • 13.1 Kyushu Demerol (Meperidine) Landscape Analysis by Major Types

    • 13.2 Kyushu Demerol (Meperidine) Landscape Analysis by Major End-Users

    14 Major Players Profiles

    • 14.1 Endo Pharmaceuticals

      • 14.1.1 Endo Pharmaceuticals Company Profile and Recent Development

      • 14.1.2 Endo Pharmaceuticals Market Performance

      • 14.1.3 Endo Pharmaceuticals Product and Service Introduction

    • 14.2 Boehringer Ingelheim

      • 14.2.1 Boehringer Ingelheim Company Profile and Recent Development

      • 14.2.2 Boehringer Ingelheim Market Performance

      • 14.2.3 Boehringer Ingelheim Product and Service Introduction

    • 14.3 Sun Pharmaceuticals

      • 14.3.1 Sun Pharmaceuticals Company Profile and Recent Development

      • 14.3.2 Sun Pharmaceuticals Market Performance

      • 14.3.3 Sun Pharmaceuticals Product and Service Introduction

    • 14.4 Purdue Pharma

      • 14.4.1 Purdue Pharma Company Profile and Recent Development

      • 14.4.2 Purdue Pharma Market Performance

      • 14.4.3 Purdue Pharma Product and Service Introduction

    • 14.5 Actavis

      • 14.5.1 Actavis Company Profile and Recent Development

      • 14.5.2 Actavis Market Performance

      • 14.5.3 Actavis Product and Service Introduction

    • 14.6 Egalet

      • 14.6.1 Egalet Company Profile and Recent Development

      • 14.6.2 Egalet Market Performance

      • 14.6.3 Egalet Product and Service Introduction

    • 14.7 Mallinckrodt Pharmaceuticals

      • 14.7.1 Mallinckrodt Pharmaceuticals Company Profile and Recent Development

      • 14.7.2 Mallinckrodt Pharmaceuticals Market Performance

      • 14.7.3 Mallinckrodt Pharmaceuticals Product and Service Introduction

    • 14.8 Janssen

      • 14.8.1 Janssen Company Profile and Recent Development

      • 14.8.2 Janssen Market Performance

      • 14.8.3 Janssen Product and Service Introduction

    • 14.9 Pfizer

      • 14.9.1 Pfizer Company Profile and Recent Development

      • 14.9.2 Pfizer Market Performance

      • 14.9.3 Pfizer Product and Service Introduction

    • 14.10 Sanofi

      • 14.10.1 Sanofi Company Profile and Recent Development

      • 14.10.2 Sanofi Market Performance

      • 14.10.3 Sanofi Product and Service Introduction

     

    The List of Tables and Figures (Totals 96 Figures and 134 Tables)

    • Figure Japan Demerol (Meperidine) Market Size and Growth Rate of Powder from 2014 to 2026

    • Figure Japan Demerol (Meperidine) Market Size and Growth Rate of Liquid from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Market Size and Growth Rate of Anesthesia

    • Figure Market Size and Growth Rate of Cough Treatment

    • Figure Market Size and Growth Rate of Diarrhea Treatment

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure Hokkaido Demerol (Meperidine) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Tohoku Demerol (Meperidine) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kanto Demerol (Meperidine) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chubu Demerol (Meperidine) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kinki Demerol (Meperidine) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chugoku Demerol (Meperidine) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Shikoku Demerol (Meperidine) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kyushu Demerol (Meperidine) Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Demerol (Meperidine) Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Demerol (Meperidine)

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Demerol (Meperidine) by Different Types from 2014 to 2026

    • Table Consumption Share of Demerol (Meperidine) by Different Types from 2014 to 2026

    • Figure Japan Demerol (Meperidine) Market Size and Growth Rate of Powder from 2014 to 2026

    • Figure Japan Demerol (Meperidine) Market Size and Growth Rate of Liquid from 2014 to 2026

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Demerol (Meperidine) by Different End-Users from 2014 to 2026

    • Table Consumption Share of Demerol (Meperidine) by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Anesthesia

    • Figure Market Size and Growth Rate of Cough Treatment

    • Figure Market Size and Growth Rate of Diarrhea Treatment

    • Table Japan Demerol (Meperidine) Production by Regions

    • Table Japan Demerol (Meperidine) Production Share by Regions

    • Figure Japan Demerol (Meperidine) Production Share by Regions in 2014

    • Figure Japan Demerol (Meperidine) Production Share by Regions in 2018

    • Figure Japan Demerol (Meperidine) Production Share by Regions in 2026

    • Table Japan Demerol (Meperidine) Consumption by Regions

    • Table Japan Demerol (Meperidine) Consumption Share by Regions

    • Figure Japan Demerol (Meperidine) Consumption Share by Regions in 2014

    • Figure Japan Demerol (Meperidine) Consumption Share by Regions in 2018

    • Figure Japan Demerol (Meperidine) Consumption Share by Regions in 2026

    • Table Hokkaido Demerol (Meperidine) Consumption by Types from 2014 to 2026

    • Table Hokkaido Demerol (Meperidine) Consumption Share by Types from 2014 to 2026

    • Figure Hokkaido Demerol (Meperidine) Consumption Share by Types in 2014

    • Figure Hokkaido Demerol (Meperidine) Consumption Share by Types in 2018

    • Figure Hokkaido Demerol (Meperidine) Consumption Share by Types in 2026

    • Table Hokkaido Demerol (Meperidine) Consumption by End-Users from 2014 to 2026

    • Table Hokkaido Demerol (Meperidine) Consumption Share by End-Users from 2014 to 2026

    • Figure Hokkaido Demerol (Meperidine) Consumption Share by End-Users in 2014

    • Figure Hokkaido Demerol (Meperidine) Consumption Share by End-Users in 2018

    • Figure Hokkaido Demerol (Meperidine) Consumption Share by End-Users in 2026

    • Table Tohoku Demerol (Meperidine) Consumption by Types from 2014 to 2026

    • Table Tohoku Demerol (Meperidine) Consumption Share by Types from 2014 to 2026

    • Figure Tohoku Demerol (Meperidine) Consumption Share by Types in 2014

    • Figure Tohoku Demerol (Meperidine) Consumption Share by Types in 2018

    • Figure Tohoku Demerol (Meperidine) Consumption Share by Types in 2026

    • Table Tohoku Demerol (Meperidine) Consumption by End-Users from 2014 to 2026

    • Table Tohoku Demerol (Meperidine) Consumption Share by End-Users from 2014 to 2026

    • Figure Tohoku Demerol (Meperidine) Consumption Share by End-Users in 2014

    • Figure Tohoku Demerol (Meperidine) Consumption Share by End-Users in 2018

    • Figure Tohoku Demerol (Meperidine) Consumption Share by End-Users in 2026

    • Table Kanto Demerol (Meperidine) Consumption by Types from 2014 to 2026

    • Table Kanto Demerol (Meperidine) Consumption Share by Types from 2014 to 2026

    • Figure Kanto Demerol (Meperidine) Consumption Share by Types in 2014

    • Figure Kanto Demerol (Meperidine) Consumption Share by Types in 2018

    • Figure Kanto Demerol (Meperidine) Consumption Share by Types in 2026

    • Table Kanto Demerol (Meperidine) Consumption by End-Users from 2014 to 2026

    • Table Kanto Demerol (Meperidine) Consumption Share by End-Users from 2014 to 2026

    • Figure Kanto Demerol (Meperidine) Consumption Share by End-Users in 2014

    • Figure Kanto Demerol (Meperidine) Consumption Share by End-Users in 2018

    • Figure Kanto Demerol (Meperidine) Consumption Share by End-Users in 2026

    • Table Chubu Demerol (Meperidine) Consumption by Types from 2014 to 2026

    • Table Chubu Demerol (Meperidine) Consumption Share by Types from 2014 to 2026

    • Figure Chubu Demerol (Meperidine) Consumption Share by Types in 2014

    • Figure Chubu Demerol (Meperidine) Consumption Share by Types in 2018

    • Figure Chubu Demerol (Meperidine) Consumption Share by Types in 2026

    • Table Chubu Demerol (Meperidine) Consumption by End-Users from 2014 to 2026

    • Table Chubu Demerol (Meperidine) Consumption Share by End-Users from 2014 to 2026

    • Figure Chubu Demerol (Meperidine) Consumption Share by End-Users in 2014

    • Figure Chubu Demerol (Meperidine) Consumption Share by End-Users in 2018

    • Figure Chubu Demerol (Meperidine) Consumption Share by End-Users in 2026

    • Table Kinki Demerol (Meperidine) Consumption by Types from 2014 to 2026

    • Table Kinki Demerol (Meperidine) Consumption Share by Types from 2014 to 2026

    • Figure Kinki Demerol (Meperidine) Consumption Share by Types in 2014

    • Figure Kinki Demerol (Meperidine) Consumption Share by Types in 2018

    • Figure Kinki Demerol (Meperidine) Consumption Share by Types in 2026

    • Table Kinki Demerol (Meperidine) Consumption by End-Users from 2014 to 2026

    • Table Kinki Demerol (Meperidine) Consumption Share by End-Users from 2014 to 2026

    • Figure Kinki Demerol (Meperidine) Consumption Share by End-Users in 2014

    • Figure Kinki Demerol (Meperidine) Consumption Share by End-Users in 2018

    • Figure Kinki Demerol (Meperidine) Consumption Share by End-Users in 2026

    • Table Chugoku Demerol (Meperidine) Consumption by Types from 2014 to 2026

    • Table Chugoku Demerol (Meperidine) Consumption Share by Types from 2014 to 2026

    • Figure Chugoku Demerol (Meperidine) Consumption Share by Types in 2014

    • Figure Chugoku Demerol (Meperidine) Consumption Share by Types in 2018

    • Figure Chugoku Demerol (Meperidine) Consumption Share by Types in 2026

    • Table Chugoku Demerol (Meperidine) Consumption by End-Users from 2014 to 2026

    • Table Chugoku Demerol (Meperidine) Consumption Share by End-Users from 2014 to 2026

    • Figure Chugoku Demerol (Meperidine) Consumption Share by End-Users in 2014

    • Figure Chugoku Demerol (Meperidine) Consumption Share by End-Users in 2018

    • Figure Chugoku Demerol (Meperidine) Consumption Share by End-Users in 2026

    • Table Shikoku Demerol (Meperidine) Consumption by Types from 2014 to 2026

    • Table Shikoku Demerol (Meperidine) Consumption Share by Types from 2014 to 2026

    • Figure Shikoku Demerol (Meperidine) Consumption Share by Types in 2014

    • Figure Shikoku Demerol (Meperidine) Consumption Share by Types in 2018

    • Figure Shikoku Demerol (Meperidine) Consumption Share by Types in 2026

    • Table Shikoku Demerol (Meperidine) Consumption by End-Users from 2014 to 2026

    • Table Shikoku Demerol (Meperidine) Consumption Share by End-Users from 2014 to 2026

    • Figure Shikoku Demerol (Meperidine) Consumption Share by End-Users in 2014

    • Figure Shikoku Demerol (Meperidine) Consumption Share by End-Users in 2018

    • Figure Shikoku Demerol (Meperidine) Consumption Share by End-Users in 2026

    • Table Kyushu Demerol (Meperidine) Consumption by Types from 2014 to 2026

    • Table Kyushu Demerol (Meperidine) Consumption Share by Types from 2014 to 2026

    • Figure Kyushu Demerol (Meperidine) Consumption Share by Types in 2014

    • Figure Kyushu Demerol (Meperidine) Consumption Share by Types in 2018

    • Figure Kyushu Demerol (Meperidine) Consumption Share by Types in 2026

    • Table Kyushu Demerol (Meperidine) Consumption by End-Users from 2014 to 2026

    • Table Kyushu Demerol (Meperidine) Consumption Share by End-Users from 2014 to 2026

    • Figure Kyushu Demerol (Meperidine) Consumption Share by End-Users in 2014

    • Figure Kyushu Demerol (Meperidine) Consumption Share by End-Users in 2018

    • Figure Kyushu Demerol (Meperidine) Consumption Share by End-Users in 2026

    • Table Company Profile and Development Status of Endo Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Endo Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Endo Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Endo Pharmaceuticals

    • Table Product and Service Introduction of Endo Pharmaceuticals

    • Table Company Profile and Development Status of Boehringer Ingelheim

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Boehringer Ingelheim

    • Figure Sales and Growth Rate Analysis of Boehringer Ingelheim

    • Figure Revenue and Market Share Analysis of Boehringer Ingelheim

    • Table Product and Service Introduction of Boehringer Ingelheim

    • Table Company Profile and Development Status of Sun Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sun Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Sun Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Sun Pharmaceuticals

    • Table Product and Service Introduction of Sun Pharmaceuticals

    • Table Company Profile and Development Status of Purdue Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Purdue Pharma

    • Figure Sales and Growth Rate Analysis of Purdue Pharma

    • Figure Revenue and Market Share Analysis of Purdue Pharma

    • Table Product and Service Introduction of Purdue Pharma

    • Table Company Profile and Development Status of Actavis

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Actavis

    • Figure Sales and Growth Rate Analysis of Actavis

    • Figure Revenue and Market Share Analysis of Actavis

    • Table Product and Service Introduction of Actavis

    • Table Company Profile and Development Status of Egalet

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Egalet

    • Figure Sales and Growth Rate Analysis of Egalet

    • Figure Revenue and Market Share Analysis of Egalet

    • Table Product and Service Introduction of Egalet

    • Table Company Profile and Development Status of Mallinckrodt Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mallinckrodt Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Mallinckrodt Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Mallinckrodt Pharmaceuticals

    • Table Product and Service Introduction of Mallinckrodt Pharmaceuticals

    • Table Company Profile and Development Status of Janssen

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Janssen

    • Figure Sales and Growth Rate Analysis of Janssen

    • Figure Revenue and Market Share Analysis of Janssen

    • Table Product and Service Introduction of Janssen

    • Table Company Profile and Development Status of Pfizer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer

    • Figure Sales and Growth Rate Analysis of Pfizer

    • Figure Revenue and Market Share Analysis of Pfizer

    • Table Product and Service Introduction of Pfizer

    • Table Company Profile and Development Status of Sanofi

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi

    • Figure Sales and Growth Rate Analysis of Sanofi

    • Figure Revenue and Market Share Analysis of Sanofi

    • Table Product and Service Introduction of Sanofi

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US